Search Results 1111-1120 of 15434 for alt

1. Safety of Regional Citrate Anticoagulation Delivered by the Multifiltratepro System in Continuous Renal Replacement Therapy - Mayo Clinic

   Severe liver disease defined as INR greater than 2.0 and total bilirubin greater than 5 mg/dL, and both AST and ALT greater than 3 times upper limit of normal.

2. A Study of Heart and Kidney Protection with Empagliflozin - Mayo Clinic

   ALT or AST >3x ULN. Hypersensitivity to empagliflozin or other SGLT-2 inhibitor. Known to be poorly compliant with clinic visits or prescribed medication ...

3. Testing an Active Form of Tamoxifen (4-hydroxytamoxifen) Delivered Through the Breast Skin to Control Ductal Carcinoma in Situ (DCIS) of the Breast - Mayo Clinic

   AST (SGOT)/ALT (SGPT) ≤ 1.5 × ULN;; Creatinine ≤ 1.5 x ULN. The effects of topical 4-OHT gel on the developing human fetus at the recommended therapeutic ...

4. JavaScript is disabled. In order to continue, we need to verify that you're not a robot. This requires JavaScript. Enable JavaScript and then reload the page.

5. Auranofin in Decreasing Pain in Patients With Paclitaxel-Induced Pain Syndrome - Mayo Clinic

   Either serum glutamate pyruvate transaminase (SGPT) (alanine aminotransferase [ALT]) or serum glutamic oxaloacetic transaminase (SGOT) (aspartate ...

6. The ELiSA Study - Evaluation of Lixivaptan in Subjects With Autosomal Dominant Polycystic Kidney Disease - Mayo Clinic

   Subjects who have experienced elevated AST or ALT (defined as ≥ 2.0 × ULN) while taking tolvaptan. Any other reason; e.g., serious mental disorders, that ...

7. Rilonacept in Subjects with Cardiac Sarcoidosis - Mayo Clinic

   AST or ALT values \> 2 × ULN 27. Any condition that, in the opinion of the investigator, could interfere with evaluation of the investigational product or ...

8. Study Of ABBV-383 Assessing Adverse Events And Clinical Activity With Subcutaneous (SC) Injection In Adult Participants With Relapsed Or Refractory Multiple Myeloma

   AST and ALT ≤ 3 × ULN;; Total bilirubin ≤ 1.5 × ULN (subjects with documented Gilbert's syndrome must have bilirubin ≤ 3 × ULN);; Estimated glomerular ...

9. A Maintenance and Long-Term Extension Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Subjects With Crohn's Disease Who Completed the Studies M14-431 or M14-433 - Mayo Clinic

   AST or ALT > 3 × upper limit of normal (ULN);; Total WBC count < 2,000/µ;; Absolute neutrophil count (ANC) < 1,000/µL;; Platelet count < 50,000/µL;; Absolute ...

10. A Study of AbGn-107 in Patients With Gastric, Colorectal, or Pancreatic Cancer - Mayo Clinic

    Aspartate aminotransferase (AST)/serum glutamic-oxalacetic transaminase (SGOT) and alanine aminotransferase (ALT)/serum glutamic-pyruvic transaminase (SGPT) ...